Skip to main content

Cardiology MCQ 70

Q. All of the following have shown mortality benefit in heart failure except?
A. Eplerenone
B. Enalapril
C. Digoxin
D. Metoprolol


Answer: C. Digoxin

Explanation:
Drugs which have shown mortality benefit in patients with heart failure with reduced ejection fraction (HFrEF) are-
1. Beta blockers
2. ACE inhibitors
3. Angiotensin receptor blockers
4. Aldosterone antagonist

Digoxin did not show any survival advantage in these patients.

None of drugs till date have shown mortality benefit in patients with heart failure with preserved ejection fraction (HFpEF).
Labels:

Comments

Post a Comment

Popular posts from this blog

Peripartum Cardiomyopathy

Peripartum Cardiomyopathy  (PPCM) •         Usually develops in last month of pregnancy or first 5 months post-delivery. •         Presents as heart failure with reduced ejection fraction (dilated cardiomyopathy) ↳        LV EF < 45%  •         PPCM is a diagnosis of exclusion. •         Risk factors → 1-      History of Hypertension, Pre-eclampsia 2-      Black women •         Incidence → 1 in 2000 live births. •         Management → 1.       Guideline directed medical therapy for HF- Beta-blockers Hydralazine plus isosorbide dinitrate  Diuretics 2.       Bromocriptine 3.       Low threshold for anticoagulation 4. ...
Post a Comment
Read more

ECG Spotter

What is the diagnosis? Click the button below to view answer: Show Answer
Post a Comment
Read more

MCQ

 Cardiology MCQ Q. Which of the following leads is not an inferior lead in ECG? A. Lead II B. Lead III C. Lead aVF D. Lead aVR Click the button below to view answer Show answer Correct answer is option D. Lead aVR
Post a Comment
Read more